Steward Partners Investment Advisory, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,675 shares of RARE stock, worth $82,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,675
Previous 1,550
8.06%
Holding current value
$82,225
Previous $63,000
47.62%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
326Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$488 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$275 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$251 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$204 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$151 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.44B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...